On September 4, 2018, Cook Group Incorporated, Cook Incorporated, and Cook Medical LLC (“Petitioners”) filed three Petitions to the USPTO’s Patent Trial and Appeal Board (“Board”) for inter partes reviews of claims 1-42 of U.S. Patent No. 8,206,427 (“the ‘427 Patent”). The ‘427 Patent is owned by Medtronic Vascular, Inc. and is drawn to an apparatus and methods for endoluminal graft placement. In each of the Petitions, Petitioners allege that claims 1-42 are obvious under 35 U.S.C. § 103 over various patent and non-patent literature documents. The inter partes reviews remain pending at the Board and are captioned IPR2018-01569, IPR2018-01570 and IPR2018-01571, respectively.
By: Jacqueline A. DiRamio